Welcome https://www.the-microbiologist.com. This site uses cookies. Read our policy.

  • Skip to main content
  • Skip to navigation
Site name
Site name
Mast navigation
  • Register
  • Sign In
  • Subscribe
Search our site
Menu
Close menu
  • Home
  • News
  • Features
  • Opinion
  • Careers
  • Topics
    • Back to parent navigation item
    • Topics
    • Early Career Research
    • One Health
    • Food Security
    • Climate Action
    • Healthy Land
    • Clean Water
    • Economic Equality
    • Ocean Sustainability
  • Regions
    • Back to parent navigation item
    • Regions
    • Africa & Middle East
    • Asia & Oceania
    • The Americas
    • UK & Europe
    • USA & Canada
  • Videos
  • AMI
    • Back to parent navigation item
    • AMI
    • Community
    • Policy
    • Publishing
    • Events
    • Special Issues
    • Diversity & Inclusion
  • Home
  • News
  • Features
  • Opinion
  • Careers
  • Topics
      • Early Career Research
      • One Health
      • Food Security
      • Climate Action
      • Healthy Land
      • Clean Water
      • Economic Equality
      • Ocean Sustainability
  • Regions
      • Africa & Middle East
      • Asia & Oceania
      • The Americas
      • UK & Europe
      • USA & Canada
  • Videos
  • AMI
      • Community
      • Policy
      • Publishing
      • Events
      • Special Issues
      • Diversity & Inclusion
  • More from navigation items

Latest news

Atlantic_forest,_northeastern_Bahia,_Brazil_(6920320111)

Study confirms effectiveness of medicinal plant against SARS-CoV-2 virus

2026-04-30T10:05:00+01:00

A study has revealed that galloylquinic acids extracted from the leaves of Copaifera lucens Dwyer, a tree endemic to Brazil primarily found in the Atlantic Forest, have a multi-targeted effect against SARS-CoV-2, the virus that causes COVID-19. 

pexels-hilal-diken-2153971208-36787548

Ancient, insect-targeting bacterial toxin may have implications for human health, agriculture, and drug discovery

2026-04-30T09:55:00+01:00

Scientists have identified and characterized a new class of Streptomyces-produced toxins that are very distantly related to the deadly toxin that causes diphtheria, a serious and contagious infection, in humans.  

pexels-gu-ko-2150570603-33013167

Pet cats that roam outdoors carry similar disease risk as feral cats, global study finds

2026-04-30T09:43:00+01:00

A new study has found that pet cats allowed to roam outside unsupervised carry infectious diseases at rates comparable to feral cats, even when they receive veterinary care, regular meals and shelter.

Low-Res_图片8

South American camelids: Potential carriers of the zoonotic pathogen Campylobacter

2026-04-30T09:37:00+01:00

A comprehensive investigation has identified a previously underappreciated source of thermotolerant Campylobacter spp. in South American camelids (SACs)—alpacas and llamas kept in Germany. The findings underscore the importance of expanding epidemiological surveillance beyond traditional livestock.

Low-Res_260424-Dr_Gabriel_Ibarra_Mejia-LM4

Significant rise in valley fever cases in El Paso linked to extreme weather and dust

2026-04-30T09:29:00+01:00

A new study has identified a significant rise in Valley fever cases in El Paso over the past decade and found strong connections between the disease and extreme weather, wind and airborne dust.

Ebola_Virus_(52466947587)

Team discovers gene pattern that could help doctors identify Ebola faster and more accurately

2026-04-30T09:22:00+01:00

Researchers have made an important discovery that could help doctors tell Ebola apart from other infections more quickly. The overlap of response by Ebola and other pathogens had made it difficult to find markers that are truly unique to Ebola.

All news content

Research

Atlantic_forest,_northeastern_Bahia,_Brazil_(6920320111)

Study confirms effectiveness of medicinal plant against SARS-CoV-2 virus

2026-04-30T10:05:00+01:00

A study has revealed that galloylquinic acids extracted from the leaves of Copaifera lucens Dwyer, a tree endemic to Brazil primarily found in the Atlantic Forest, have a multi-targeted effect against SARS-CoV-2, the virus that causes COVID-19. 

pexels-hilal-diken-2153971208-36787548

Ancient, insect-targeting bacterial toxin may have implications for human health, agriculture, and drug discovery

2026-04-30T09:55:00+01:00

Scientists have identified and characterized a new class of Streptomyces-produced toxins that are very distantly related to the deadly toxin that causes diphtheria, a serious and contagious infection, in humans.  

pexels-gu-ko-2150570603-33013167

Pet cats that roam outdoors carry similar disease risk as feral cats, global study finds

2026-04-30T09:43:00+01:00

A new study has found that pet cats allowed to roam outside unsupervised carry infectious diseases at rates comparable to feral cats, even when they receive veterinary care, regular meals and shelter.

More Research

Industry

Low-Res_Infectious Disease- TB and Non-TB- Scientists- Dartois and Dick- Lab-Office (33)

CDI breakthroughs lead to new drug development deal for deadly NTM bacteria

2026-04-22T09:11:00+01:00

Scientists have developed new compounds against non-tuberculous mycobacteria which are now the subject of a new collaboration and license agreement with the Switzerland-based and publicly listed BioVersys AG. 

Low-Res_mev2

Vanderbilt Center for Antibody Therapeutics signs agreement to develop anti-measles antibody treatment

2026-04-07T09:40:00+01:00

The Vanderbilt Center for Antibody Therapeutics has signed an option agreement with Saravir Biopharma Inc. for the company to develop human monoclonal antibodies isolated in the laboratory of James Crowe Jr., MD, for the treatment and prevention of measles.

Laboratory Decontamination (Environment System) (4)

Cleanroom specialist Total Clean Air appointed European partner for US-based biodecontamination firm, TOMI

2026-03-24T12:23:00+00:00

UK-BASED cleanroom engineering company Total Clean Air (TCA), a UKAS ISO 17025-accredited cleanroom constructor, has been appointed European partner for US-based decontamination technology firm TOMI®Environmental Solutions.

more industry

Special Issue

Innovation

Low-Res_cover_image

Simple new system keeps microscopes in focus automatically

2026-04-30T08:18:00+01:00

Anyone who has ever used a microscope knows that it takes time to bring a sample into sharp focus. Now a team of scientists has developed an inexpensive robust fix for this problem that involves little more than a couple of LED lights and some physics-based processing.

Low-Res_UCSD-JacobsSchool-2604-Steinmetz-gel-04042-8MP

Stick-on gel offers new way to treat and monitor plants

2026-04-29T08:45:00+01:00

Scientists have developed an adhesive gel that can be loaded with substances, such as small molecule drugs or nanoparticles, and applied directly onto a plant to deliver those materials into its tissues. In tests, a gel loaded with antibiotics cleared a bacterial infection in a plant within about 48 hours.

Low-Res__AAA0362

A universal toolkit for editing bacterial DNA

2026-04-27T16:02:00+01:00

A major collaboration involving nine labs has transferred a particularly useful DNA editing system from E. coli into 14 new species of bacteria, spanning three major branches of the bacterial family tree.

more innovation

People

Low-Res_ProfessorTorbjornLundh_professorPhilipGerlee_foto Setta Aspström Chalmers

The handbook that can prepare countries for the next pandemic

2026-04-29T09:53:00+01:00

A new handbook has been published to pave the way for better decision-making and greater preparedness for the next pandemic. It provides practical guidance on how mathematical models can be used to inform decision-making, and how the results can be communicated in times of crisis.

Influenza_A_H5N1_Virus_Particles

Global Virus Network statement on H5N1 vaccine developments

2026-04-28T11:04:00+01:00

The new vaccine momentum reflects the growing urgency of avian influenza (H5N1) threat and reinforces the need for coordinated global preparedness.

Bacteriophage

Phage therapy at a turning point: Valencia 2026 to define the next era of antibacterial medicine

2026-04-28T09:14:00+01:00

The Targeting Phage Therapy 2026 Congress will bring together leading scientists, clinicians, microbiologists, engineers, biotech leaders, regulators, hospital teams, start-ups, and innovators to ask: How can phage therapy move from promising science to accessible, validated, and deployable medicine?

more people

  • Issues
  • Contact us
  • Topics A-Z
  • Writers A-Z
  • Advertise with us
  • Editorial Team
  • In the Loop Newsletter

Bringing the international microbiology community together to advance scientific impact.
appliedmicrobiology.org

© Applied Microbiology International
  • Cookie Policy
  • Privacy
  • Terms of use
  • © 2022 The Microbiologist

Site powered by Webvision Cloud